Side-by-side comparison of AI visibility scores, market position, and capabilities
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
US YC W20 open-source CBRS private LTE network anyone can deploy at $1.1M revenue 2024; first decentralized cellular network for enterprises/ISPs/individuals competing with Celona for private cellular infrastructure in factories, campuses, and underserved areas.
Ukama is a United States-based decentralized open-source cellular network platform — backed by Y Combinator (W20) — providing enterprises, ISPs, and individuals with the hardware and software to deploy and control their own private LTE-based cellular networks using CBRS (Citizens Broadband Radio Service) spectrum and other bands, generating $1.1 million in annual revenue in 2024 with a 7-person team. Founded in 2020, Ukama positions as the first cellular network that anyone can independently deploy and manage — offering free data within self-deployed coverage areas and global roaming capabilities outside them, enabling use cases from private industrial IoT networks and campus cellular coverage to community-owned internet infrastructure in underserved areas.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.